{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:35Z","timestamp":1790613815198,"version":"4.1.0"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LO 1556\/4-1"],"award-info":[{"award-number":["LO 1556\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR179 TP17"],"award-info":[{"award-number":["TRR179 TP17"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR209"],"award-info":[{"award-number":["TRR209"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TP A2"],"award-info":[{"award-number":["TP A2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2019,2,4]]},"DOI":"10.1007\/s00430-018-0566-x","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T11:26:41Z","timestamp":1538998001000},"page":"3-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-7608","authenticated-orcid":false,"given":"Volker","family":"Lohmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"566_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1056\/NEJM197504102921502","volume":"292","author":"SM Feinstone","year":"1975","unstructured":"Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292:767\u2013770","journal-title":"N Engl J Med"},{"key":"566_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S0016-5085(19)32325-X","volume":"69","author":"RG Knodell","year":"1975","unstructured":"Knodell RG, Conrad ME, Dienstag JL, Bell CJ (1975) Etiological spectrum of post-transfusion hepatitis. Gastroenterology 69:1278\u20131285","journal-title":"Gastroenterology"},{"key":"566_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/infdis\/139.5.511","volume":"139","author":"A Tateda","year":"1979","unstructured":"Tateda A, Kikuchi K, Numazaki Y, Shirachi R, Ishida N (1979) Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis 139:511\u2013518","journal-title":"J Infect Dis"},{"key":"566_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1423-0410.1983.tb01889.x","volume":"44","author":"JM Hernandez","year":"1983","unstructured":"Hernandez JM, Piqueras J, Carrera A, Triginer J (1983) Posttransfusion hepatitis in Spain. A prospective study. Vox Sang 44:231\u2013237","journal-title":"Vox Sang"},{"key":"566_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0016-5085(85)90150-7","volume":"88","author":"DW Bradley","year":"1985","unstructured":"Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE (1985) Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology 88:773\u2013779","journal-title":"Gastroenterology"},{"key":"566_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/infdis\/156.4.636","volume":"156","author":"LF He","year":"1987","unstructured":"He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH (1987) Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 156:636\u2013640","journal-title":"J Infect Dis"},{"key":"566_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359\u2013362","journal-title":"Science"},{"key":"566_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1126\/science.2496467","volume":"244","author":"G Kuo","year":"1989","unstructured":"Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362\u2013364","journal-title":"Science"},{"key":"566_CR9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/80394","volume":"6","author":"HJ Alter","year":"2000","unstructured":"Alter HJ, Houghton M (2000) Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 6:1082\u20131086","journal-title":"Nat Med"},{"key":"566_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1099\/0022-1317-81-7-1631","volume":"81 Part 7","author":"R Bartenschlager","year":"2000","unstructured":"Bartenschlager R, Lohmann V (2000) Replication of hepatitis C virus. J Gen Virol 81 Part 7:1631\u20131648","journal-title":"J Gen Virol"},{"key":"566_CR11","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","volume":"88","author":"QL Choo","year":"1991","unstructured":"Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina SR, Barr PJ (1991) et al Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451\u20132455","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR12","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","volume":"13","author":"MJ Alter","year":"2007","unstructured":"Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436\u20132441","journal-title":"World J Gastroenterol"},{"key":"566_CR13","doi-asserted-by":"publisher","first-page":"20509","DOI":"10.1073\/pnas.1105797108","volume":"108","author":"MH Powdrill","year":"2011","unstructured":"Powdrill MH, Tchesnokov EP, Kozak RA, Russell RS, Martin R, Svarovskaia ES, Mo H, Kouyos RD, Gotte M (2011) Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance. Proc Natl Acad Sci USA 108:20509\u201320513","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","volume":"59","author":"DB Smith","year":"2014","unstructured":"Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59:318\u2013327","journal-title":"Hepatology"},{"key":"566_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.07.002","author":"J Vermehren","year":"2018","unstructured":"Vermehren J, Park JS, Jacobson I, Zeuzem S (2018) Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2018.07.002","journal-title":"J Hepatol"},{"key":"566_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0378-1119(90)90102-W","volume":"91","author":"K Takeuchi","year":"1990","unstructured":"Takeuchi K, Boonmar S, Kubo Y, Katayama T, Harada H, Ohbayashi A, Choo QL, Kuo G, Houghton M, Saito I et al (1990) Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis. Gene 91:287\u2013291","journal-title":"Gene"},{"key":"566_CR17","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1073\/pnas.88.8.3392","volume":"88","author":"N Ogata","year":"1991","unstructured":"Ogata N, Alter HJ, Miller RH, Purcell RH (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88:3392\u20133396","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR18","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","volume":"94","author":"M Yanagi","year":"1997","unstructured":"Yanagi M, Purcell RH, Emerson SU, Bukh J (1997) Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94:8738\u20138743","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.277.5325.570","volume":"277","author":"AA Kolykhalov","year":"1997","unstructured":"Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM (1997) Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570\u2013574","journal-title":"Science"},{"key":"566_CR20","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1099\/0022-1317-71-12-3027","volume":"71","author":"K Takeuchi","year":"1990","unstructured":"Takeuchi K, Kubo Y, Boonmar S, Watanabe Y, Katayama T, Choo QL, Kuo G, Houghton M, Saito I, Miyamura T (1990) The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 71:3027\u20133033","journal-title":"J Gen Virol"},{"key":"566_CR21","first-page":"167","volume":"60","author":"H Okamoto","year":"1990","unstructured":"Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, Miyakawa Y, Mayumi M (1990) The 5\u2032-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 60:167\u2013177","journal-title":"Jpn J Exp Med"},{"key":"566_CR22","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1093\/nar\/17.24.10367","volume":"17","author":"Y Kubo","year":"1989","unstructured":"Kubo Y, Takeuchi K, Boonmar S, Katayama T, Choo QL, Kuo G, Weiner AJ, Bradley DW, Houghton M, Saito I et al (1989) A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res 17:10367\u201310372","journal-title":"Nucleic Acids Res"},{"key":"566_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","volume":"74","author":"P Simmonds","year":"1993","unstructured":"Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391\u20132399","journal-title":"J Gen Virol"},{"key":"566_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1099\/0022-1317-75-5-1053","volume":"75","author":"P Simmonds","year":"1994","unstructured":"Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC (1994) Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 75:1053\u20131061","journal-title":"J Gen Virol"},{"key":"566_CR25","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1093\/nar\/20.23.6410","volume":"20","author":"H Okamoto","year":"1992","unstructured":"Okamoto H, Kanai N, Mishiro S (1992) Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates. Nucleic Acids Res 20:6410","journal-title":"Nucleic Acids Res"},{"key":"566_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0042-6822(92)90762-E","volume":"188","author":"H Okamoto","year":"1992","unstructured":"Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S (1992) Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 188:331\u2013341","journal-title":"Virology"},{"key":"566_CR27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/jvi.67.3.1385-1395.1993","volume":"67","author":"A Grakoui","year":"1993","unstructured":"Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM (1993) Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385\u20131395","journal-title":"J Virol"},{"key":"566_CR28","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1128\/jvi.67.7.4017-4026.1993","volume":"67","author":"L Tomei","year":"1993","unstructured":"Tomei L, Failla C, Santolini E, De Francesco R, La MN (1993) NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67:4017\u20134026","journal-title":"J Virol"},{"key":"566_CR29","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/jvi.67.5.2832-2843.1993","volume":"67","author":"A Grakoui","year":"1993","unstructured":"Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM (1993) Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 67:2832\u20132843","journal-title":"J Virol"},{"key":"566_CR30","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/jvi.67.7.3835-3844.1993","volume":"67","author":"R Bartenschlager","year":"1993","unstructured":"Bartenschlager R, Ahlborn LL, Mous J, Jacobsen H (1993) Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3\/4 and NS4\/5 junctions. J Virol 67:3835\u20133844","journal-title":"J Virol"},{"key":"566_CR31","doi-asserted-by":"publisher","first-page":"10583","DOI":"10.1073\/pnas.90.22.10583","volume":"90","author":"A Grakoui","year":"1993","unstructured":"Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM (1993) A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 90:10583\u201310587","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR32","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1128\/jvi.67.8.4665-4675.1993","volume":"67","author":"M Hijikata","year":"1993","unstructured":"Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K (1993) Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67:4665\u20134675","journal-title":"J Virol"},{"key":"566_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF01313774","volume":"133","author":"Y Hirowatari","year":"1993","unstructured":"Hirowatari Y, Hijikata M, Tanji Y, Nyunoya H, Mizushima H, Kimura K, Tanaka T, Kato N, Shimotohno K (1993) Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector. Arch Virol 133:349\u2013356","journal-title":"Arch Virol"},{"key":"566_CR34","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1128\/jvi.69.12.7519-7528.1995","volume":"69","author":"R Bartenschlager","year":"1995","unstructured":"Bartenschlager R, Lohmann V, Wilkinson T, Koch JO (1995) Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 69:7519\u20137528","journal-title":"J Virol"},{"key":"566_CR35","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.68.6.3753-3760.1994","volume":"68","author":"C Failla","year":"1994","unstructured":"Failla C, Tomei L, De Francesco R (1994) Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol 68:3753\u20133760","journal-title":"J Virol"},{"key":"566_CR36","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1128\/jvi.69.7.4373-4380.1995","volume":"69","author":"C Lin","year":"1995","unstructured":"Lin C, Thomson JA, Rice CM (1995) A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 69:4373\u20134380","journal-title":"J Virol"},{"key":"566_CR37","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/jvi.67.10.6152-6158.1993","volume":"67","author":"JA Suzich","year":"1993","unstructured":"Suzich JA, Tamura JK, Palmer HF, Warrener P, Grakoui A, Rice CM, Feinstone SM, Collett MS (1993) Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol 67:6152\u20136158","journal-title":"J Virol"},{"key":"566_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1006\/bbrc.1995.2447","volume":"215","author":"DW Kim","year":"1995","unstructured":"Kim DW, Gwack Y, Han JH, Choe J (1995) C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun 215:160\u2013166","journal-title":"Biochem Biophys Res Commun"},{"key":"566_CR39","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/jvi.69.7.3980-3986.1995","volume":"69","author":"Y Tanji","year":"1995","unstructured":"Tanji Y, Kaneko T, Satoh S, Shimotohno K (1995) Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69:3980\u20133986","journal-title":"J Virol"},{"key":"566_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1006\/bbrc.1994.2667","volume":"205","author":"T Kaneko","year":"1994","unstructured":"Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K, Shimotohno K (1994) Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 205:320\u2013326","journal-title":"Biochem Biophys Res Commun"},{"key":"566_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/j.1460-2075.1996.tb00329.x","volume":"15","author":"SE Behrens","year":"1996","unstructured":"Behrens SE, Tomei L, De Francesco R (1996) Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 15:12\u201322","journal-title":"EMBO J"},{"key":"566_CR42","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1128\/jvi.71.11.8416-8428.1997","volume":"71","author":"V Lohmann","year":"1997","unstructured":"Lohmann V, Korner F, Herian U, Bartenschlager R (1997) Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol 71:8416\u20138428","journal-title":"J Virol"},{"key":"566_CR43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nature04080","volume":"436","author":"R De Francesco","year":"2005","unstructured":"De Francesco R, Migliaccio G (2005) Challenges and successes in developing new therapies for hepatitis C. Nature 436:953\u2013960","journal-title":"Nature"},{"key":"566_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1006\/viro.1996.0659","volume":"226","author":"B Hahm","year":"1996","unstructured":"Hahm B, Back SH, Lee TG, Wimmer E, Jang SK (1996) Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity. Virology 226:318\u2013326","journal-title":"Virology"},{"key":"566_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00174-8","volume":"60","author":"VE Buckwold","year":"2003","unstructured":"Buckwold VE, Beer BE, Donis RO (2003) Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res 60:1\u201315","journal-title":"Antiviral Res"},{"key":"566_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/bega.1999.0073","volume":"14","author":"R Bartenschlager","year":"2000","unstructured":"Bartenschlager R, Lohmann V (2000) Replication of the hepatitis C virus. Baillieres Clin Gastroenterol 14:241\u2013254","journal-title":"Baillieres Clin Gastroenterol"},{"key":"566_CR47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1006\/viro.1994.1381","volume":"202","author":"RE Lanford","year":"1994","unstructured":"Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR (1994) Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT\/PCR. Virology 202:606\u2013614","journal-title":"Virology"},{"key":"566_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF01310568","volume":"134","author":"T Gunji","year":"1994","unstructured":"Gunji T, Kato N, Hijikata M, Hayashi K, Saitoh S, Shimotohno K (1994) Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch Virol 134:293\u2013302","journal-title":"Arch Virol"},{"key":"566_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/viro.1994.1053","volume":"198","author":"JC Boyer","year":"1994","unstructured":"Boyer JC, Haenni AL (1994) Infectious transcripts and cDNA clones of RNA viruses. Virology 198:415\u2013426","journal-title":"Virology"},{"key":"566_CR50","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1073\/pnas.88.5.1711","volume":"88","author":"JH Han","year":"1991","unstructured":"Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp OP, Kuo G, Choo QL, Houghton M (1991) Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5\u2032 untranslated region and poly(A) tails at the 3\u2032 end. Proc Natl Acad Sci USA 88:1711\u20131715","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR51","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1128\/jvi.70.6.3363-3371.1996","volume":"70","author":"AA Kolykhalov","year":"1996","unstructured":"Kolykhalov AA, Feinstone SM, Rice CM (1996) Identification of a highly conserved sequence element at the 3\u2032 terminus of hepatitis C virus genome RNA. J Virol 70:3363\u20133371","journal-title":"J Virol"},{"key":"566_CR52","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1006\/bbrc.1995.2526","volume":"215","author":"T Tanaka","year":"1995","unstructured":"Tanaka T, Kato N, Cho MJ, Shimotohno K (1995) A novel sequence found at the 3\u2032 terminus of hepatitis C virus genome. Biochem Biophys Res Commun 215:744\u2013749","journal-title":"Biochem Biophys Res Commun"},{"key":"566_CR53","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/jvi.70.2.763-770.1996","volume":"70","author":"RJ Moormann","year":"1996","unstructured":"Moormann RJ, van Gennip HG, Miedema GK, Hulst MM, van Rijn PA (1996) Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus. J Virol 70:763\u2013770","journal-title":"J Virol"},{"key":"566_CR54","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"KJ Blight","year":"2000","unstructured":"Blight KJ, Kolykhalov AA, Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290:1972\u20131974","journal-title":"Science"},{"key":"566_CR55","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1128\/JVI.77.5.3181-3190.2003","volume":"77","author":"KJ Blight","year":"2003","unstructured":"Blight KJ, McKeating JA, Marcotrigiano J, Rice CM (2003) Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77:3181\u20133190","journal-title":"J Virol"},{"key":"566_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, K\u00f6rner F, Koch JO, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110\u2013113","journal-title":"Science"},{"key":"566_CR57","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.239.4839.487","volume":"239","author":"RK Saiki","year":"1988","unstructured":"Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487\u2013491","journal-title":"Science"},{"key":"566_CR58","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1128\/jvi.68.8.5045-5055.1994","volume":"68","author":"R Bartenschlager","year":"1994","unstructured":"Bartenschlager R, Ahlborn LL, Mous J, Jacobsen H (1994) Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 68:5045\u20135055","journal-title":"J Virol"},{"key":"566_CR59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/jvi.69.1.198-205.1995","volume":"69","author":"R Bartenschlager","year":"1995","unstructured":"Bartenschlager R, Ahlborn LL, Yasargil K, Mous J, Jacobsen H (1995) Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol 69:198\u2013205","journal-title":"J Virol"},{"key":"566_CR60","first-page":"289","volume":"369","author":"L Delang","year":"2013","unstructured":"Delang L, Neyts J, Vliegen I, Abrignani S, Neddermann P, De Francesco R (2013) Hepatitis C virus-specific directly acting antiviral drugs. Curr Top Microbiol Immunol 369:289\u2013320","journal-title":"Curr Top Microbiol Immunol"},{"key":"566_CR61","unstructured":"Lohmann V (1997) Untersuchungen zur Partikelmorphogenese und Replikation des Hepatitis C Virus auf der Basis klonierter Voll\u00e4ngengenome, PhD thesis, University of Mainz"},{"key":"566_CR62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/viro.1998.9311","volume":"249","author":"V Lohmann","year":"1998","unstructured":"Lohmann V, Roos A, Korner F, Koch JO, Bartenschlager R (1998) Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Virology 249:108\u2013118","journal-title":"Virology"},{"key":"566_CR63","doi-asserted-by":"publisher","first-page":"10807","DOI":"10.1074\/jbc.274.16.10807","volume":"274","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, Overton H, Bartenschlager R (1999) Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP. J Biol Chem 274:10807\u201310815","journal-title":"J Biol Chem"},{"key":"566_CR64","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1128\/JVI.73.9.7138-7146.1999","volume":"73","author":"JO Koch","year":"1999","unstructured":"Koch JO, Bartenschlager R (1999) Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J Virol 73:7138\u20137146","journal-title":"J Virol"},{"key":"566_CR65","doi-asserted-by":"publisher","first-page":"14416","DOI":"10.1073\/pnas.212532699","volume":"99","author":"J Bukh","year":"2002","unstructured":"Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA 99:14416\u201314421","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR66","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/JVI.72.3.2364-2372.1998","volume":"72","author":"SE Behrens","year":"1998","unstructured":"Behrens SE, Grassmann CW, Thiel HJ, Meyers G, Tautz N (1998) Characterization of an autonomous subgenomic pestivirus RNA replicon. J Virol 72:2364\u20132372","journal-title":"J Virol"},{"key":"566_CR67","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/jvi.71.2.1497-1505.1997","volume":"71","author":"AA Khromykh","year":"1997","unstructured":"Khromykh AA, Westaway EG (1997) Subgenomic replicons of the flavivirus Kunjin: construction and applications. J Virol 71:1497\u20131505","journal-title":"J Virol"},{"key":"566_CR68","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/j.1460-2075.1994.tb06587.x","volume":"13","author":"JA Lemm","year":"1994","unstructured":"Lemm JA, Rumenapf T, Strauss EG, Strauss JH, Rice CM (1994) Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus- and plus-strand RNA synthesis. EMBO J 13:2925\u20132934","journal-title":"EMBO J"},{"key":"566_CR69","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/JVI.75.3.1252-1264.2001","volume":"75","author":"T Pietschmann","year":"2001","unstructured":"Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R (2001) Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 75:1252\u20131264","journal-title":"J Virol"},{"key":"566_CR70","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1128\/JVI.77.3.2029-2037.2003","volume":"77","author":"RW Hardy","year":"2003","unstructured":"Hardy RW, Marcotrigiano J, Blight KJ, Majors JE, Rice CM (2003) Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells. J Virol 77:2029\u20132037","journal-title":"J Virol"},{"key":"566_CR71","doi-asserted-by":"publisher","first-page":"12001","DOI":"10.1128\/JVI.76.23.12001-12007.2002","volume":"76","author":"N Ali","year":"2002","unstructured":"Ali N, Tardif KD, Siddiqui A (2002) Cell-free replication of the hepatitis C virus subgenomic replicon. J Virol 76:12001\u201312007","journal-title":"J Virol"},{"key":"566_CR72","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1128\/JVI.77.3.2295-2300.2003","volume":"77","author":"VC Lai","year":"2003","unstructured":"Lai VC, Dempsey S, Lau JY, Hong Z, Zhong W (2003) In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus. J Virol 77:2295\u20132300","journal-title":"J Virol"},{"key":"566_CR73","doi-asserted-by":"publisher","first-page":"50301","DOI":"10.1074\/jbc.M305684200","volume":"278","author":"Y Miyanari","year":"2003","unstructured":"Miyanari Y, Hijikata M, Yamaji M, Hosaka M, Takahashi H, Shimotohno K (2003) Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J Biol Chem 278:50301\u201350308","journal-title":"J Biol Chem"},{"key":"566_CR74","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1128\/JVI.79.21.13594-13605.2005","volume":"79","author":"D Quinkert","year":"2005","unstructured":"Quinkert D, Bartenschlager R, Lohmann V (2005) Quantitative analysis of the hepatitis C virus replication complex. J Virol 79:13594\u201313605","journal-title":"J Virol"},{"key":"566_CR75","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.1082604","volume":"300","author":"E Foy","year":"2003","unstructured":"Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale Jr M (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145\u20131148","journal-title":"Science"},{"key":"566_CR76","doi-asserted-by":"publisher","first-page":"13038","DOI":"10.1073\/pnas.0405152101","volume":"101","author":"MJ Evans","year":"2004","unstructured":"Evans MJ, Rice CM, Goff SP (2004) Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci USA 101:13038\u201313043","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR77","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","volume":"19","author":"K Watashi","year":"2005","unstructured":"Watashi K, Ishii N, Hijikata M, Inoue D, Murata T, Miyanari Y, Shimotohno K (2005) Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell 19:111\u2013122","journal-title":"Mol Cell"},{"key":"566_CR78","doi-asserted-by":"publisher","first-page":"20374","DOI":"10.1074\/jbc.M210785200","volume":"278","author":"A Pause","year":"2003","unstructured":"Pause A, Kukolj G, Bailey M, Brault M, Do F, Halmos T, Lagace L, Maurice R, Marquis M, McKercher G, Pellerin C, Pilote L, Thibeault D, Lamarre D (2003) An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J Biol Chem 278:20374\u201320380","journal-title":"J Biol Chem"},{"key":"566_CR79","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/jhep.2003.50449","volume":"38","author":"K Watashi","year":"2003","unstructured":"Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K (2003) Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 38:1282\u20131288","journal-title":"Hepatology"},{"key":"566_CR80","doi-asserted-by":"publisher","first-page":"49164","DOI":"10.1074\/jbc.M305041200","volume":"278","author":"G Migliaccio","year":"2003","unstructured":"Migliaccio G, Tomassini JE, Carroll SS, Tomei L, Altamura S, Bhat B, Bartholomew L, Bosserman MR, Ceccacci A, Colwell LF, Cortese R, De Francesco R, Eldrup AB, Getty KL, Hou XS, Lafemina RL, Ludmerer SW, MacCoss M, McMasters DR, Stahlhut MW, Olsen DB, Hazuda DJ, Flores OA (2003) Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem 278:49164\u201349170","journal-title":"J Biol Chem"},{"key":"566_CR81","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1128\/AAC.00556-10","volume":"54","author":"RA Fridell","year":"2010","unstructured":"Fridell RA, Qiu D, Wang C, Valera L, Gao M (2010) Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system. Antimicrob Agents Chemother 54:3641\u20133650","journal-title":"Antimicrob Agents Chemother"},{"key":"566_CR82","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1099\/0022-1317-82-4-723","volume":"82","author":"M Frese","year":"2001","unstructured":"Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R (2001) Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82:723\u2013733","journal-title":"J Gen Virol"},{"key":"566_CR83","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/jhep.2002.31770","volume":"35","author":"M Frese","year":"2002","unstructured":"Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O, Bartenschlager R (2002) Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694\u2013703","journal-title":"Hepatology"},{"key":"566_CR84","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrd942","volume":"1","author":"R Bartenschlager","year":"2002","unstructured":"Bartenschlager R (2002) Hepatitis C virus replicons: potential role for drug development. Nat Rev Drug Discov 1:911\u2013916","journal-title":"Nat Rev Drug Discov"},{"key":"566_CR85","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/2047-783X-16-7-303","volume":"16","author":"J Vermehren","year":"2011","unstructured":"Vermehren J, Sarrazin C (2011) New hepatitis C therapies in clinical development. Eur J Med Res 16:303\u2013314","journal-title":"Eur J Med Res"},{"key":"566_CR86","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/JVI.77.5.3007-3019.2003","volume":"77","author":"V Lohmann","year":"2003","unstructured":"Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R (2003) Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 77:3007\u20133019","journal-title":"J Virol"},{"key":"566_CR87","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1128\/JVI.75.3.1437-1449.2001","volume":"75","author":"V Lohmann","year":"2001","unstructured":"Lohmann V, K\u00f6rner F, Dobierzewska A, Bartenschlager R (2001) Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75:1437\u20131449","journal-title":"J Virol"},{"key":"566_CR88","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1128\/JVI.75.10.4614-4624.2001","volume":"75","author":"N Krieger","year":"2001","unstructured":"Krieger N, Lohmann V, Bartenschlager R (2001) Enhancement of hepatitis C virus RNA replication by cell culture\u2014adaptive mutations. J Virol 75:4614\u20134624","journal-title":"J Virol"},{"key":"566_CR89","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1128\/JVI.79.5.3187-3194.2005","volume":"79","author":"N Appel","year":"2005","unstructured":"Appel N, Pietschmann T, Bartenschlager R (2005) Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol 79:3187\u20133194","journal-title":"J Virol"},{"key":"566_CR90","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chom.2010.12.002","volume":"9","author":"S Reiss","year":"2011","unstructured":"Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, Kaderali L, Poenisch M, Blankenburg H, Hiet MS, Longerich T, Diehl S, Ramirez F, Balla T, Rohr K, Kaul A, Buhler S, Pepperkok R, Lengauer T, Albrecht M, Eils R, Schirmacher P, Lohmann V, Bartenschlager R (2011) Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9:32\u201345","journal-title":"Cell Host Microbe"},{"key":"566_CR91","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.1038\/nmicrobiol.2016.247","volume":"2","author":"C Harak","year":"2016","unstructured":"Harak C, Meyrath M, Romero-Brey I, Schenk C, Gondeau C, Schult P, Esser-Nobis K, Saeed M, Neddermann P, Schnitzler P, Gotthardt D, Perez-Del-Pulgar S, Neumann-Haefelin C, Thimme R, Meuleman P, Vondran FW, De Francesco R, Rice CM, Bartenschlager R, Lohmann V (2016) Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture. Nat Microbiol 2:16247","journal-title":"Nat Microbiol"},{"key":"566_CR92","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1128\/JVI.76.8.4008-4021.2002","volume":"76","author":"T Pietschmann","year":"2002","unstructured":"Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76:4008\u20134021","journal-title":"J Virol"},{"key":"566_CR93","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1053\/j.gastro.2018.03.020","volume":"154","author":"O Grunvogel","year":"2018","unstructured":"Grunvogel O, Colasanti O, Lee JY, Kloss V, Belouzard S, Reustle A, Esser-Nobis K, Hesebeck-Brinckmann J, Mutz P, Hoffmann K, Mehrabi A, Koschny R, Vondran FWR, Gotthardt D, Schnitzler P, Neumann-Haefelin C, Thimme R, Binder M, Bartenschlager R, Dubuisson J, Dalpke AH, Lohmann V (2018) Secretion of hepatitis C virus replication intermediates reduces activation of toll-like receptor 3 in hepatocytes. Gastroenterology 154:2237\u20132251","journal-title":"Gastroenterology"},{"key":"566_CR94","doi-asserted-by":"publisher","first-page":"e1000475","DOI":"10.1371\/journal.ppat.1000475","volume":"5","author":"T Pietschmann","year":"2009","unstructured":"Pietschmann T, Zayas M, Meuleman P, Long G, Appel N, Koutsoudakis G, Kallis S, Leroux-Roels G, Lohmann V, Bartenschlager R (2009) Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog 5:e1000475","journal-title":"PLoS Pathog"},{"key":"566_CR95","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791\u2013796","journal-title":"Nat Med"},{"key":"566_CR96","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/hep.21829","volume":"46","author":"M Binder","year":"2007","unstructured":"Binder M, Kochs G, Bartenschlager R, Lohmann V (2007) Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46:1365\u20131374","journal-title":"Hepatology"},{"key":"566_CR97","doi-asserted-by":"publisher","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","volume":"76","author":"KJ Blight","year":"2002","unstructured":"Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76:13001\u201313014","journal-title":"J Virol"},{"key":"566_CR98","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1128\/JVI.77.5.2928-2935.2003","volume":"77","author":"EM Murray","year":"2003","unstructured":"Murray EM, Grobler JA, Markel EJ, Pagnoni MF, Paonessa G, Simon AJ, Flores OA (2003) Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells. J Virol 77:2928\u20132935","journal-title":"J Virol"},{"key":"566_CR99","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1099\/vir.0.18997-0","volume":"84","author":"M Frese","year":"2003","unstructured":"Frese M, Barth K, Kaul A, Lohmann V, Schwarzle V, Bartenschlager R (2003) Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. J Gen Virol 84:1253\u20131259","journal-title":"J Gen Virol"},{"key":"566_CR100","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","volume":"79","author":"R Sumpter Jr","year":"2005","unstructured":"Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689\u20132699","journal-title":"J Virol"},{"key":"566_CR101","doi-asserted-by":"publisher","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","volume":"5","author":"A Kaul","year":"2009","unstructured":"Kaul A, Stauffer S, Berger C, Pertel T, Schmitt J, Kallis S, Lopez MZ, Lohmann V, Luban J, Bartenschlager R (2009) Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog 5:e1000546","journal-title":"PLoS Pathog"},{"key":"566_CR102","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1126\/science.1113329","volume":"309","author":"CL Jopling","year":"2005","unstructured":"Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577\u20131581","journal-title":"Science"},{"key":"566_CR103","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1128\/JVI.05843-11","volume":"85","author":"CM Narbus","year":"2011","unstructured":"Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, Zeiner GM, Evans MJ (2011) HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85:12087\u201312092","journal-title":"J Virol"},{"key":"566_CR104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.virol.2012.11.007","volume":"436","author":"PA Thibault","year":"2013","unstructured":"Thibault PA, Huys A, Dhillon P, Wilson JA (2013) MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells. Virology 436:179\u2013190","journal-title":"Virology"},{"key":"566_CR105","volume-title":"Characterization of host cell determinants for hepatitis C virus replication in cell culture, Dissertation","author":"M Binder","year":"2007","unstructured":"Binder M (2007) Characterization of host cell determinants for hepatitis C virus replication in cell culture, Dissertation. University of Heidelberg, Heidelberg"},{"key":"566_CR106","doi-asserted-by":"publisher","first-page":"e1003561","DOI":"10.1371\/journal.ppat.1003561","volume":"9","author":"M Binder","year":"2013","unstructured":"Binder M, Sulaimanov N, Clausznitzer D, Schulze M, Huber CM, Lenz SM, Schloder JP, Trippler M, Bartenschlager R, Lohmann V, Kaderali L (2013) Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle. PLoS Pathog 9:e1003561","journal-title":"PLoS Pathog"},{"key":"566_CR107","doi-asserted-by":"publisher","first-page":"13778","DOI":"10.1128\/JVI.79.21.13778-13793.2005","volume":"79","author":"MP Windisch","year":"2005","unstructured":"Windisch MP, Frese M, Kaul A, Trippler M, Lohmann V, Bartenschlager R (2005) Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 79:13778\u201313793","journal-title":"J Virol"},{"key":"566_CR108","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/JVI.78.1.491-501.2004","volume":"78","author":"S Ali","year":"2004","unstructured":"Ali S, Pellerin C, Lamarre D, Kukolj G (2004) Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J Virol 78:491\u2013501","journal-title":"J Virol"},{"key":"566_CR109","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1128\/JVI.79.1.592-596.2005","volume":"79","author":"T Kato","year":"2005","unstructured":"Kato T, Date T, Miyamoto M, Zhao Z, Mizokami M, Wakita T (2005) Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol 79:592\u2013596","journal-title":"J Virol"},{"key":"566_CR110","doi-asserted-by":"publisher","first-page":"9204","DOI":"10.1128\/JVI.77.17.9204-9210.2003","volume":"77","author":"Q Zhu","year":"2003","unstructured":"Zhu Q, Guo JT, Seeger C (2003) Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 77:9204\u20139210","journal-title":"J Virol"},{"key":"566_CR111","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1743-422X-3-89","volume":"3","author":"SL Uprichard","year":"2006","unstructured":"Uprichard SL, Chung J, Chisari FV, Wakita T (2006) Replication of a hepatitis C virus replicon clone in mouse cells. Virol J 3:89","journal-title":"Virol J"},{"key":"566_CR112","doi-asserted-by":"publisher","first-page":"7364","DOI":"10.1128\/JVI.00586-06","volume":"80","author":"KS Chang","year":"2006","unstructured":"Chang KS, Cai Z, Zhang C, Sen GC, Williams BR, Luo G (2006) Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J Virol 80:7364\u20137374","journal-title":"J Virol"},{"key":"566_CR113","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1053\/j.gastro.2011.06.010","volume":"141","author":"G Long","year":"2011","unstructured":"Long G, Hiet MS, Windisch MP, Lee JY, Lohmann V, Bartenschlager R (2011) Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology 141:1057\u20131066","journal-title":"Gastroenterology"},{"key":"566_CR114","doi-asserted-by":"publisher","first-page":"22371","DOI":"10.1074\/jbc.M311120200","volume":"279","author":"T Date","year":"2004","unstructured":"Date T, Kato T, Miyamoto M, Zhao Z, Yasui K, Mizokami M, Wakita T (2004) Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem 279:22371\u201322376","journal-title":"J Biol Chem"},{"key":"566_CR115","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40139-016-0113-7","volume":"4","author":"RE Schwartz","year":"2016","unstructured":"Schwartz RE, Bram Y, Frankel A (2016) Pluripotent stem cell-derived hepatocyte-like cells: a tool to study infectious disease. Curr Pathobiol Rep 4:147\u2013156","journal-title":"Curr Pathobiol Rep"},{"key":"566_CR116","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcmgh.2017.11.005","volume":"5","author":"N Gural","year":"2018","unstructured":"Gural N, Mancio-Silva L, He J, Bhatia SN (2018) Engineered livers for infectious diseases. Cell Mol Gastroenterol Hepatol 5:131\u2013144","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"566_CR117","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2018.02.005","volume":"23","author":"Y Baktash","year":"2018","unstructured":"Baktash Y, Madhav A, Coller KE, Randall G (2018) Single particle imaging of polarized hepatoma organoids upon hepatitis C virus infection reveals an ordered and sequential entry process. Cell Host Microbe 23:382\u2013394","journal-title":"Cell Host Microbe"},{"key":"566_CR118","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/hep.25908","volume":"56","author":"P Metz","year":"2012","unstructured":"Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R (2012) Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology 56:2082\u20132093","journal-title":"Hepatology"},{"key":"566_CR119","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","volume":"61","author":"MH Heim","year":"2014","unstructured":"Heim MH, Thimme R (2014) Innate and adaptive immune responses in HCV infections. J Hepatol 61:S14\u2013S25","journal-title":"J Hepatol"},{"key":"566_CR120","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/hep.26770","volume":"59","author":"S Wieland","year":"2014","unstructured":"Wieland S, Makowska Z, Campana B, Calabrese D, Dill MT, Chung J, Chisari FV, Heim MH (2014) Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology 59:2121\u20132130","journal-title":"Hepatology"},{"key":"566_CR121","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.chom.2014.01.007","volume":"15","author":"T Sheahan","year":"2014","unstructured":"Sheahan T, Imanaka N, Marukian S, Dorner M, Liu P, Ploss A, Rice CM (2014) Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. Cell Host Microbe 15:190\u2013202","journal-title":"Cell Host Microbe"},{"key":"566_CR122","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/j.gastro.2009.07.050","volume":"137","author":"Y Liang","year":"2009","unstructured":"Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D, Cicalese L, Weiss H, Vargas G, Lemon SM (2009) Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137:1448\u20131458","journal-title":"Gastroenterology"},{"key":"566_CR123","doi-asserted-by":"publisher","first-page":"12047","DOI":"10.1128\/JVI.75.24.12047-12057.2001","volume":"75","author":"P Friebe","year":"2001","unstructured":"Friebe P, Lohmann V, Krieger N, Bartenschlager R (2001) Sequences in the 5\u2032 nontranslated region of hepatitis C virus required for RNA replication. J Virol 75:12047\u201312057","journal-title":"J Virol"},{"key":"566_CR124","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1128\/JVI.76.11.5326-5338.2002","volume":"76","author":"P Friebe","year":"2002","unstructured":"Friebe P, Bartenschlager R (2002) Genetic analysis of sequences in the 3\u2032 nontranslated region of hepatitis C virus that are important for RNA replication. J Virol 76:5326\u20135338","journal-title":"J Virol"},{"key":"566_CR125","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/jm401401n","volume":"57","author":"V Lohmann","year":"2014","unstructured":"Lohmann V, Bartenschlager R (2014) On the history of hepatitis C virus cell culture systems. J Med Chem 57:1627\u20131642","journal-title":"J Med Chem"},{"key":"566_CR126","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1128\/JVI.75.18.8516-8523.2001","volume":"75","author":"JT Guo","year":"2001","unstructured":"Guo JT, Bichko VV, Seeger C (2001) Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75:8516\u20138523","journal-title":"J Virol"},{"key":"566_CR127","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1128\/JVI.76.6.2997-3006.2002","volume":"76","author":"M Ikeda","year":"2002","unstructured":"Ikeda M, Yi M, Li K, Lemon SM (2002) Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76:2997\u20133006","journal-title":"J Virol"},{"key":"566_CR128","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.virusres.2007.02.022","volume":"127","author":"R Bartenschlager","year":"2007","unstructured":"Bartenschlager R, Sparacio S (2007) Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res 127:195\u2013207","journal-title":"Virus Res"},{"key":"566_CR129","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/viro.2002.1652","volume":"304","author":"M Yi","year":"2002","unstructured":"Yi M, Bodola F, Lemon SM (2002) Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein. Virology 304:197\u2013210","journal-title":"Virology"},{"key":"566_CR130","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/hep.510300137","volume":"30","author":"MR Beard","year":"1999","unstructured":"Beard MR, Abell G, Honda M, Carroll A, Gartland M, Clarke B, Suzuki K, Lanford R, Sangar DV, Lemon SM (1999) An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology 30:316\u2013324","journal-title":"Hepatology"},{"key":"566_CR131","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.1074\/jbc.M212602200","volume":"278","author":"JA Grobler","year":"2003","unstructured":"Grobler JA, Markel EJ, Fay JF, Graham DJ, Simcoe AL, Ludmerer SW, Murray EM, Migliaccio G, Flores OA (2003) Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase. J Biol Chem 278:16741\u201316746","journal-title":"J Biol Chem"},{"key":"566_CR132","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature14899","volume":"524","author":"M Saeed","year":"2015","unstructured":"Saeed M, Andreo U, Chung HY, Espiritu C, Branch AD, Silva JM, Rice CM (2015) SEC14L2 enables pan-genotype HCV replication in cell culture. Nature 524:471\u2013475","journal-title":"Nature"},{"key":"566_CR133","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1128\/AAC.01256-12","volume":"56","author":"M Saeed","year":"2012","unstructured":"Saeed M, Scheel TK, Gottwein JM, Marukian S, Dustin LB, Bukh J, Rice CM (2012) Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells. Antimicrob Agents Chemother 56:5365\u20135373","journal-title":"Antimicrob Agents Chemother"},{"key":"566_CR134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.gastro.2012.09.017","volume":"144","author":"M Saeed","year":"2013","unstructured":"Saeed M, Gondeau C, Hmwe S, Yokokawa H, Date T, Suzuki T, Kato T, Maurel P, Wakita T (2013) Replication of hepatitis C virus genotype 3a in cultured cells. Gastroenterology 144:56\u201358","journal-title":"Gastroenterology"},{"key":"566_CR135","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.gastro.2012.09.033","volume":"144","author":"B Peng","year":"2013","unstructured":"Peng B, Yu M, Xu S, Lee YJ, Tian Y, Yang H, Chan K, Mo H, McHutchison J, Delaney W, Cheng G (2013) Development of robust hepatitis C virus genotype 4 subgenomic replicons. Gastroenterology 144:59\u201361","journal-title":"Gastroenterology"},{"key":"566_CR136","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1128\/AAC.03534-14","volume":"58","author":"CN Wose Kinge","year":"2014","unstructured":"Wose Kinge CN, Espiritu C, Prabdial-Sing N, Sithebe NP, Saeed M, Rice CM (2014) Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents. Antimicrob Agents Chemother 58:5386\u20135394","journal-title":"Antimicrob Agents Chemother"},{"key":"566_CR137","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1128\/AAC.01780-13","volume":"58","author":"M Yu","year":"2014","unstructured":"Yu M, Peng B, Chan K, Gong R, Yang H, Delaney W, Cheng G (2014) Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture. Antimicrob Agents Chemother 58:2638\u20132646","journal-title":"Antimicrob Agents Chemother"},{"key":"566_CR138","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.virol.2017.11.003","volume":"514","author":"G Camus","year":"2018","unstructured":"Camus G, Xu S, Han B, Lu J, Dvory-Sobol H, Yu M, Cheng G, Miller MD, Doehle BP, Mo H (2018) Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems. Virology 514:134\u2013141","journal-title":"Virology"},{"key":"566_CR139","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","volume":"125","author":"T Kato","year":"2003","unstructured":"Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, Mizokami M, Wakita T (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808\u20131817","journal-title":"Gastroenterology"},{"key":"566_CR140","doi-asserted-by":"publisher","first-page":"11926","DOI":"10.1128\/JVI.01008-09","volume":"83","author":"P Simister","year":"2009","unstructured":"Simister P, Schmitt M, Geitmann M, Wicht O, Danielson UH, Klein R, Bressanelli S, Lohmann V (2009) Structural and functional analysis of hepatitis C virus strain JFH1 polymerase. J Virol 83:11926\u201311939","journal-title":"J Virol"},{"key":"566_CR141","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1128\/JVI.02177-10","volume":"85","author":"M Schmitt","year":"2011","unstructured":"Schmitt M, Scrima N, Radujkovic D, Caillet-Saguy C, Simister PC, Friebe P, Wicht O, Klein R, Bartenschlager R, Lohmann V, Bressanelli S (2011) A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes. J Virol 85:2565\u20132581","journal-title":"J Virol"},{"key":"566_CR142","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1128\/JVI.02088-06","volume":"81","author":"A Murayama","year":"2007","unstructured":"Murayama A, Date T, Morikawa K, Akazawa D, Miyamoto M, Kaga M, Ishii K, Suzuki T, Kato T, Mizokami M, Wakita T (2007) The NS3 helicase and NS5B-to-3\u2032X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J Virol 81:8030\u20138040","journal-title":"J Virol"},{"key":"566_CR143","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J Zhong","year":"2005","unstructured":"Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102:9294\u20139299","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR144","first-page":"17","volume":"369","author":"E Steinmann","year":"2013","unstructured":"Steinmann E, Pietschmann T (2013) Cell culture systems for hepatitis C virus. Curr Top Microbiol Immunol 369:17\u201348","journal-title":"Curr Top Microbiol Immunol"},{"key":"566_CR145","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"T Pietschmann","year":"2006","unstructured":"Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103:7408\u20137413","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR146","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.22673","volume":"49","author":"JM Gottwein","year":"2009","unstructured":"Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, Knudsen ML, Hoegh AM, Bukh J (2009) Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49:364\u2013377","journal-title":"Hepatology"},{"key":"566_CR147","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1128\/JVI.01605-10","volume":"85","author":"TK Scheel","year":"2011","unstructured":"Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, Spengler U, Weis N, Bukh J (2011) Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 85:2891\u20132906","journal-title":"J Virol"},{"key":"566_CR148","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM (2005) Complete replication of hepatitis C virus in cell culture. Science 309:623\u2013626","journal-title":"Science"},{"key":"566_CR149","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/viro.1999.9889","volume":"262","author":"M Yanagi","year":"1999","unstructured":"Yanagi M, Purcell RH, Emerson SU, Bukh J (1999) Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virology 262:250\u2013263","journal-title":"Virology"},{"key":"566_CR150","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.1128\/JVI.01362-07","volume":"81","author":"A Kaul","year":"2007","unstructured":"Kaul A, Woerz I, Meuleman P, Leroux-Roels G, Bartenschlager R (2007) Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 81:13168\u201313179","journal-title":"J Virol"},{"key":"566_CR151","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1128\/JVI.02460-05","volume":"80","author":"G Koutsoudakis","year":"2006","unstructured":"Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80:5308\u20135320","journal-title":"J Virol"},{"key":"566_CR152","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1128\/JVI.02144-06","volume":"81","author":"T Schaller","year":"2007","unstructured":"Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R (2007) Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 81:4591\u20134603","journal-title":"J Virol"},{"key":"566_CR153","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1128\/JVI.01534-06","volume":"81","author":"G Koutsoudakis","year":"2007","unstructured":"Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T (2007) The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 81:588\u2013598","journal-title":"J Virol"},{"key":"566_CR154","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrmicro3098","volume":"11","author":"BD Lindenbach","year":"2013","unstructured":"Lindenbach BD, Rice CM (2013) The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 11:688\u2013700","journal-title":"Nat Rev Microbiol"},{"key":"566_CR155","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","volume":"19","author":"R Bartenschlager","year":"2011","unstructured":"Bartenschlager R, Penin F, Lohmann V, Andre P (2011) Assembly of infectious hepatitis C virus particles. Trends Microbiol 19:95\u2013103","journal-title":"Trends Microbiol"},{"key":"566_CR156","first-page":"199","volume":"369","author":"BD Lindenbach","year":"2013","unstructured":"Lindenbach BD (2013) Virion assembly and release. Curr Top Microbiol Immunol 369:199\u2013218","journal-title":"Curr Top Microbiol Immunol"},{"key":"566_CR157","first-page":"87","volume":"369","author":"MB Zeisel","year":"2013","unstructured":"Zeisel MB, Felmlee DJ, Baumert TF (2013) Hepatitis C virus entry. Curr Top Microbiol Immunol 369:87\u2013112","journal-title":"Curr Top Microbiol Immunol"},{"key":"566_CR158","first-page":"167","volume":"369","author":"V Lohmann","year":"2013","unstructured":"Lohmann V (2013) Hepatitis C virus RNA replication. Curr Top Microbiol Immunol 369:167\u2013198","journal-title":"Curr Top Microbiol Immunol"},{"key":"566_CR159","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1073\/pnas.0511218103","volume":"103","author":"BD Lindenbach","year":"2006","unstructured":"Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103:3805\u20133809","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR160","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2013.11.009","volume":"146","author":"YP Li","year":"2014","unstructured":"Li YP, Ramirez S, Humes D, Jensen SB, Gottwein JM, Bukh J (2014) Differential sensitivity of 5\u2032UTR-NS5A recombinants of hepatitis C virus genotypes 1\u20136 to protease and NS5A inhibitors. Gastroenterology 146:812\u2013821","journal-title":"Gastroenterology"},{"key":"566_CR161","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1073\/pnas.0510727103","volume":"103","author":"M Yi","year":"2006","unstructured":"Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103:2310\u20132315","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR162","doi-asserted-by":"publisher","first-page":"19757","DOI":"10.1073\/pnas.1218260109","volume":"109","author":"YP Li","year":"2012","unstructured":"Li YP, Ramirez S, Jensen SB, Purcell RH, Gottwein JM, Bukh J (2012) Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proc Natl Acad Sci USA 109:19757\u201319762","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR163","doi-asserted-by":"publisher","first-page":"E1101","DOI":"10.1073\/pnas.1203829109","volume":"109","author":"YP Li","year":"2012","unstructured":"Li YP, Ramirez S, Gottwein JM, Scheel TK, Mikkelsen L, Purcell RH, Bukh J (2012) Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains. Proc Natl Acad Sci USA 109:E1101\u2013E1110","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR164","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1053\/j.gastro.2018.02.017","volume":"154","author":"LV Pham","year":"2018","unstructured":"Pham LV, Ramirez S, Gottwein JM, Fahnoe U, Li YP, Pedersen J, Bukh J (2018) HCV genotype 6a escape from and resistance to velpatasvir, pibrentasvir, and sofosbuvir in robust infectious cell culture models. Gastroenterology 154:2194\u20132208","journal-title":"Gastroenterology"},{"key":"566_CR165","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1053\/j.gastro.2016.07.013","volume":"151","author":"S Ramirez","year":"2016","unstructured":"Ramirez S, Mikkelsen LS, Gottwein JM, Bukh J (2016) Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir. Gastroenterology 151:973\u2013985","journal-title":"Gastroenterology"},{"key":"566_CR166","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrmicro3046","volume":"11","author":"R Bartenschlager","year":"2013","unstructured":"Bartenschlager R, Lohmann V, Penin F (2013) The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat Rev Microbiol 11:482\u2013496","journal-title":"Nat Rev Microbiol"},{"key":"566_CR167","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2013.04.020","volume":"99","author":"HY Kim","year":"2013","unstructured":"Kim HY, Li X, Jones CT, Rice CM, Garcia JM, Genovesio A, Hansen MA, Windisch MP (2013) Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals. Antiviral Res 99:6\u201311","journal-title":"Antiviral Res"},{"key":"566_CR168","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.antiviral.2018.07.014","volume":"158","author":"S Ramirez","year":"2018","unstructured":"Ramirez S, Bukh J (2018) Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: essential tools in testing of antivirals and emerging vaccine strategies. Antiviral Res 158:264\u2013287","journal-title":"Antiviral Res"},{"key":"566_CR169","doi-asserted-by":"publisher","first-page":"e0156731","DOI":"10.1371\/journal.pone.0156731","volume":"11","author":"J Dietz","year":"2016","unstructured":"Dietz J, Rupp D, Susser S, Vermehren J, Peiffer KH, Filmann N, Bon D, Kuntzen T, Mauss S, Grammatikos G, Perner D, Berkowski C, Herrmann E, Zeuzem S, Bartenschlager R, Sarrazin C (2016) Investigation of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy. PLoS One 11:e0156731","journal-title":"PLoS One"},{"key":"566_CR170","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJM198612183152503","volume":"315","author":"JH Hoofnagle","year":"1986","unstructured":"Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di BA, Peters M, Waggoner JG, Park Y, Jones EA (1986) Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 315:1575\u20131578","journal-title":"N Engl J Med"},{"key":"566_CR171","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","volume":"362","author":"T Poynard","year":"2003","unstructured":"Poynard T, Yuen MF, Ratziu V, Lai CL (2003) Viral hepatitis C. Lancet 362:2095\u20132100","journal-title":"Lancet"},{"key":"566_CR172","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature08960","volume":"465","author":"M Gao","year":"2010","unstructured":"Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O\u2019Boyle DR, Lemm JA, Wang C, Knipe JO, Chien C, Colonno RJ, Grasela DM, Meanwell NA, Hamann LG (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465:96\u2013100","journal-title":"Nature"},{"key":"566_CR173","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/hep.21102","volume":"43","author":"J Paeshuyse","year":"2006","unstructured":"Paeshuyse J, Kaul A, De Clercq E, Rosenwirth B, Dumont JM, Scalfaro P, Bartenschlager R, Neyts J (2006) The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 43:761\u2013770","journal-title":"Hepatology"},{"key":"566_CR174","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1128\/JVI.02614-07","volume":"82","author":"F Yang","year":"2008","unstructured":"Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R, Tang H (2008) Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J Virol 82:5269\u20135278","journal-title":"J Virol"},{"key":"566_CR175","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.1128\/JVI.02418-08","volume":"83","author":"J Borawski","year":"2009","unstructured":"Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, Bantscheff M, Schirle M, Bouwmeester T, Mathy JE, Lin K, Compton T, Labow M, Wiedmann B, Gaither LA (2009) Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol 83:10058\u201310074","journal-title":"J Virol"},{"key":"566_CR176","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.virol.2009.02.039","volume":"387","author":"FH Vaillancourt","year":"2009","unstructured":"Vaillancourt FH, Pilote L, Cartier M, Lippens J, Liuzzi M, Bethell RC, Cordingley MG, Kukolj G (2009) Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 387:5\u201310","journal-title":"Virology"},{"key":"566_CR177","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.chom.2009.02.001","volume":"5","author":"AW Tai","year":"2009","unstructured":"Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RT (2009) A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5:298\u2013307","journal-title":"Cell Host Microbe"},{"key":"566_CR178","doi-asserted-by":"publisher","first-page":"16410","DOI":"10.1073\/pnas.0907439106","volume":"106","author":"Q Li","year":"2009","unstructured":"Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, Liang TJ, Elledge SJ (2009) A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci USA 106:16410\u201316415","journal-title":"Proc Natl Acad Sci USA"},{"key":"566_CR179","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMp1400986","volume":"370","author":"RT Chung","year":"2014","unstructured":"Chung RT, Baumert TF (2014) Curing chronic hepatitis C\u2014the arc of a medical triumph. N Engl J Med 370:1576\u20131578","journal-title":"N Engl J Med"},{"key":"566_CR180","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/510043a","volume":"510","author":"CM Rice","year":"2014","unstructured":"Rice CM, Saeed M (2014) Hepatitis C: treatment triumphs. Nature 510:43\u201344","journal-title":"Nature"},{"key":"566_CR181","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature02099","volume":"426","author":"D Lamarre","year":"2003","unstructured":"Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, Bonneau P, Bos M, Cameron DR, Cartier M, Cordingley MG, Faucher AM, Goudreau N, Kawai SH, Kukolj G, Lagace L, LaPlante SR, Narjes H, Poupart MA, Rancourt J, Sentjens RE, St GR, Simoneau B, Steinmann G, Thibeault D, Tsantrizos YS, Weldon SM, Yong CL, Llinas-Brunet M (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426:186\u2013189","journal-title":"Nature"},{"key":"566_CR182","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1517\/13543784.14.9.1129","volume":"14","author":"N Goudreau","year":"2005","unstructured":"Goudreau N, Llinas-Brunet M (2005) The therapeutic potential of NS3 protease inhibitors in HCV infection. Expert Opin Investig Drugs 14:1129\u20131144","journal-title":"Expert Opin Investig Drugs"},{"key":"566_CR183","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14656566.2012.660524","volume":"13","author":"N Forestier","year":"2012","unstructured":"Forestier N, Zeuzem S (2012) Telaprevir for the treatment of hepatitis C. Expert Opin Pharmacother 13:593\u2013606","journal-title":"Expert Opin Pharmacother"},{"key":"566_CR184","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.clinthera.2012.08.009","volume":"34","author":"MH Chang","year":"2012","unstructured":"Chang MH, Gordon LA, Fung HB (2012) Boceprevir: a protease inhibitor for the treatment of hepatitis C. Clin Ther 34:2021\u20132038","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"566_CR185","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","volume":"56","author":"C Sarrazin","year":"2012","unstructured":"Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM (2012) Antiviral strategies in hepatitis C virus infection. J Hepatol 56(Suppl 1):S88\u2013S100","journal-title":"J Hepatol"},{"key":"566_CR186","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2893.2000.00218.x","volume":"7","author":"V Lohmann","year":"2000","unstructured":"Lohmann V, Roos A, Korner F, Koch JO, Bartenschlager R (2000) Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J Viral Hepat 7:167\u2013174","journal-title":"J Viral Hepat"},{"key":"566_CR187","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1021\/jm0502788","volume":"48","author":"JL Clark","year":"2005","unstructured":"Clark JL, Hollecker L, Mason JC, Stuyver LJ, Tharnish PM, Lostia S, McBrayer TR, Schinazi RF, Watanabe KA, Otto MJ, Furman PA, Stec WJ, Patterson SE, Pankiewicz KW (2005) Design, synthesis, and antiviral activity of 2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. J Med Chem 48:5504\u20135508","journal-title":"J Med Chem"},{"key":"566_CR188","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1021\/jm100863x","volume":"53","author":"MJ Sofia","year":"2010","unstructured":"Sofia MJ, Bao D, Chang W, Du J, Nagarathnam D, Rachakonda S, Reddy PG, Ross BS, Wang P, Zhang HR, Bansal S, Espiritu C, Keilman M, Lam AM, Steuer HM, Niu C, Otto MJ, Furman PA (2010) Discovery of a beta-d-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J Med Chem 53:7202\u20137218","journal-title":"J Med Chem"},{"key":"566_CR189","doi-asserted-by":"publisher","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","volume":"285","author":"E Murakami","year":"2010","unstructured":"Murakami E, Tolstykh T, Bao H, Niu C, Steuer HM, Bao D, Chang W, Espiritu C, Bansal S, Lam AM, Otto MJ, Sofia MJ, Furman PA (2010) Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977. J Biol Chem 285:34337\u201334347","journal-title":"J Biol Chem"},{"key":"566_CR190","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJMoa1315722","volume":"370","author":"JJ Feld","year":"2014","unstructured":"Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, Weiland O, Aguilar H, Xiong J, Pilot-Matias T, DaSilva-Tillmann B, Larsen L, Podsadecki T, Bernstein B (2014) Treatment of HCV with ABT-450\/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 370:1594\u20131603","journal-title":"N Engl J Med"},{"key":"566_CR191","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","volume":"370","author":"P Ferenci","year":"2014","unstructured":"Ferenci P, Bernstein D, Lalezari J, Cohen D, Luo Y, Cooper C, Tam E, Marinho RT, Tsai N, Nyberg A, Box TD, Younes Z, Enayati P, Green S, Baruch Y, Bhandari BR, Caruntu FA, Sepe T, Chulanov V, Janczewska E, Rizzardini G, Gervain J, Planas R, Moreno C, Hassanein T, Xie W, King M, Podsadecki T, Reddy KR (2014) ABT-450\/r-ombitasvir and dasabuvir with or without ribavirin for HCV. N Engl J Med 370:1983\u20131992","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"566_CR192","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/liv.13638","volume":"38","author":"C Hezode","year":"2018","unstructured":"Hezode C (2018) Treatment of hepatitis C: Results in real life. Liver Int 38(Suppl 1):21\u201327","journal-title":"Liver Int"},{"key":"566_CR193","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","volume":"370","author":"N Afdhal","year":"2014","unstructured":"Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Brau N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Mangia A, Marcellin P (2014) Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 370:1889\u20131898","journal-title":"N Engl J Med"},{"key":"566_CR194","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","volume":"370","author":"N Afdhal","year":"2014","unstructured":"Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, Nahass R, Ghalib R, Gitlin N, Herring R, Lalezari J, Younes ZH, Pockros PJ, Di Bisceglie AM, Arora S, Subramanian GM, Zhu Y, Dvory-Sobol H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Sulkowski M, Kwo P (2014) Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med 370:1483\u20131493","journal-title":"N Engl J Med"},{"key":"566_CR195","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJMc1401726","volume":"370","author":"HS Dhaliwal","year":"2014","unstructured":"Dhaliwal HS, Nampoothiri RV (2014) Daclatasvir plus sofosbuvir for HCV infection. N Engl J Med 370:1560","journal-title":"N Engl J Med"},{"key":"566_CR196","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","volume":"370","author":"KV Kowdley","year":"2014","unstructured":"Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, Shiffman ML, Schiff E, Ghalib R, Ryan M, Rustgi V, Chojkier M, Herring R, Di Bisceglie AM, Pockros PJ, Subramanian GM, An D, Svarovskaia E, Hyland RH, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Pound D, Fried MW (2014) Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med 370:1879\u20131888","journal-title":"N Engl J Med"},{"key":"566_CR197","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1306218","volume":"370","author":"MS Sulkowski","year":"2014","unstructured":"Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, Lawitz E, Lok AS, Hinestrosa F, Thuluvath PJ, Schwartz H, Nelson DR, Everson GT, Eley T, Wind-Rotolo M, Huang SP, Gao M, Hernandez D, McPhee F, Sherman D, Hindes R, Symonds W, Pasquinelli C, Grasela DM (2014) Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 370:211\u2013221","journal-title":"N Engl J Med"},{"key":"566_CR198","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJMoa1306218","volume":"370","author":"MS Sulkowski","year":"2014","unstructured":"Sulkowski MS, Jacobson IM, Nelson DR (2014) Daclatasvir plus sofosbuvir for HCV infection. N Engl J Med 370:1560\u20131561","journal-title":"N Engl J Med"},{"key":"566_CR199","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa1316145","volume":"370","author":"S Zeuzem","year":"2014","unstructured":"Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, Illeperuma A, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Weiland O, Reesink HW, Ferenci P, Hezode C, Esteban R (2014) Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 370:1993\u20132001","journal-title":"N Engl J Med"},{"key":"566_CR200","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cid\/ciu697","volume":"59","author":"ES Svarovskaia","year":"2014","unstructured":"Svarovskaia ES, Dvory-Sobol H, Parkin N, Hebner C, Gontcharova V, Martin R, Ouyang W, Han B, Xu S, Ku K, Chiu S, Gane E, Jacobson IM, Nelson DR, Lawitz E, Wyles DL, Bekele N, Brainard D, Symonds WT, McHutchison JG, Miller MD, Mo H (2014) Infrequent development of resistance in genotype 1\u20136 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials. Clin Infect Dis 59:1666\u20131674","journal-title":"Clin Infect Dis"},{"key":"566_CR201","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMc1601160","volume":"374","author":"N Assy","year":"2016","unstructured":"Assy N, Barhoum M (2016) Sofosbuvir and Velpatasvir for patients with HCV infection. N Engl J Med 374:1687","journal-title":"N Engl J Med"},{"key":"566_CR202","first-page":"1688","volume":"374","author":"MP Curry","year":"2016","unstructured":"Curry MP, Charlton M (2016) Sofosbuvir and Velpatasvir for patients with HCV infection. N Engl J Med 374:1688","journal-title":"N Engl J Med"},{"key":"566_CR203","first-page":"1688","volume":"374","author":"JJ Feld","year":"2016","unstructured":"Feld JJ, Zeuzem S (2016) Sofosbuvir and Velpatasvir for patients with HCV infection. N Engl J Med 374:1688\u20131689","journal-title":"N Engl J Med"},{"key":"566_CR204","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMc1601160","volume":"374","author":"GR Foster","year":"2016","unstructured":"Foster GR, Mangia A, Sulkowski M (2016) Sofosbuvir and velpatasvir for patients with HCV infection. N Engl J Med 374:1687\u20131688","journal-title":"N Engl J Med"},{"key":"566_CR205","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1172\/JCI90179","volume":"126","author":"CL Williams","year":"2016","unstructured":"Williams CL (2016) Ralf Bartenschlager, Charles Rice, and Michael Sofia are honored with the 2016 Lasker\u2013DeBakey Clinical Medical Research Award. J Clin Investig 126:3639\u20133644","journal-title":"J Clin Investig"},{"key":"566_CR206","first-page":"113","volume":"369","author":"D Moradpour","year":"2013","unstructured":"Moradpour D, Penin F (2013) Hepatitis C virus proteins: from structure to function. Curr Top Microbiol Immunol 369:113\u2013142","journal-title":"Curr Top Microbiol Immunol"},{"key":"566_CR207","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1128\/JVI.79.2.896-909.2005","volume":"79","author":"N Appel","year":"2005","unstructured":"Appel N, Herian U, Bartenschlager R (2005) Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A. J Virol 79:896\u2013909","journal-title":"J Virol"},{"key":"566_CR208","doi-asserted-by":"publisher","first-page":"e1000035","DOI":"10.1371\/journal.ppat.1000035","volume":"4","author":"N Appel","year":"2008","unstructured":"Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R (2008) Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4:e1000035","journal-title":"PLoS Pathog"},{"key":"566_CR209","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1128\/JVI.02343-09","volume":"84","author":"P Backes","year":"2010","unstructured":"Backes P, Quinkert D, Reiss S, Binder M, Zayas M, Rescher U, Gerke V, Bartenschlager R, Lohmann V (2010) Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol 84:5775\u20135789","journal-title":"J Virol"},{"key":"566_CR210","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1021\/acs.biochem.7b00212","volume":"56","author":"A Badillo","year":"2017","unstructured":"Badillo A, Receveur-Brechot V, Sarrazin S, Cantrelle FX, Delolme F, Fogeron ML, Molle J, Montserret R, Bockmann A, Bartenschlager R, Lohmann V, Lippens G, Ricard-Blum S, Hanoulle X, Penin F (2017) Overall structural model of NS5A protein from hepatitis C virus and modulation by mutations confering resistance of virus replication to cyclosporin A. Biochemistry 56:3029\u20133048","journal-title":"Biochemistry"},{"key":"566_CR211","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1074\/jbc.M809244200","volume":"284","author":"X Hanoulle","year":"2009","unstructured":"Hanoulle X, Badillo A, Wieruszeski JM, Verdegem D, Landrieu I, Bartenschlager R, Penin F, Lippens G (2009) Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis\/trans isomerase activity of cyclophilins A and B. J Biol Chem 284:13589\u201313601","journal-title":"J Biol Chem"},{"key":"566_CR212","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2015.04.015","volume":"63","author":"MS Hiet","year":"2015","unstructured":"Hiet MS, Bauhofer O, Zayas M, Roth H, Tanaka Y, Schirmacher P, Willemsen J, Grunvogel O, Bender S, Binder M, Lohmann V, Lotteau V, Ruggieri A, Bartenschlager R (2015) Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A. J Hepatol 63:829\u2013837","journal-title":"J Hepatol"},{"key":"566_CR213","doi-asserted-by":"publisher","first-page":"40835","DOI":"10.1074\/jbc.M404761200","volume":"279","author":"F Penin","year":"2004","unstructured":"Penin F, Brass V, Appel N, Ramboarina S, Montserret R, Ficheux D, Blum HE, Bartenschlager R, Moradpour D (2004) Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. J Biol Chem 279:40835\u201340843","journal-title":"J Biol Chem"},{"key":"566_CR214","doi-asserted-by":"publisher","first-page":"e1003359","DOI":"10.1371\/journal.ppat.1003359","volume":"9","author":"S Reiss","year":"2013","unstructured":"Reiss S, Harak C, Romero-Brey I, Radujkovic D, Klein R, Ruggieri A, Rebhan I, Bartenschlager R, Lohmann V (2013) The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A. PLoS Pathog 9:e1003359","journal-title":"PLoS Pathog"},{"key":"566_CR215","doi-asserted-by":"publisher","first-page":"e00759","DOI":"10.1128\/mBio.00759-15","volume":"6","author":"I Romero-Brey","year":"2015","unstructured":"Romero-Brey I, Berger C, Kallis S, Kolovou A, Paul D, Lohmann V, Bartenschlager R (2015) NS5A domain 1 and polyprotein cleavage kinetics are critical for induction of double-membrane vesicles associated with hepatitis C virus replication. MBio 6:e00759","journal-title":"MBio"},{"key":"566_CR216","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virol.2014.05.016","volume":"462\u2013463","author":"CA Eberle","year":"2014","unstructured":"Eberle CA, Zayas M, Stukalov A, Pichlmair A, Alvisi G, Muller AC, Bennett KL, Bartenschlager R, Superti-Furga G (2014) The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production. Virology 462\u2013463:34\u201341","journal-title":"Virology"},{"key":"566_CR217","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ncb1631","volume":"9","author":"Y Miyanari","year":"2007","unstructured":"Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9:1089\u20131097","journal-title":"Nat Cell Biol"},{"key":"566_CR218","doi-asserted-by":"publisher","first-page":"e1005376","DOI":"10.1371\/journal.ppat.1005376","volume":"12","author":"M Zayas","year":"2016","unstructured":"Zayas M, Long G, Madan V, Bartenschlager R (2016) Coordination of hepatitis C virus assembly by distinct regulatory regions in nonstructural protein 5A. PLoS Pathog 12:e1005376","journal-title":"PLoS Pathog"},{"key":"566_CR219","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.bmcl.2009.01.066","volume":"19","author":"I Conte","year":"2009","unstructured":"Conte I, Giuliano C, Ercolani C, Narjes F, Koch U, Rowley M, Altamura S, De Francesco R, Neddermann P, Migliaccio G, Stansfield I (2009) Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture. Bioorg Med Chem Lett 19:1779\u20131783","journal-title":"Bioorg Med Chem Lett"},{"key":"566_CR220","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1128\/JVI.01360-09","volume":"84","author":"JA Lemm","year":"2010","unstructured":"Lemm JA, O\u2019Boyle D, Liu M, Nower PT, Colonno R, Deshpande MS, Snyder LB, Martin SW, St Laurent DR, Serrano-Wu MH, Romine JL, Meanwell NA, Gao M (2010) Identification of hepatitis C virus NS5A inhibitors. J Virol 84:482\u2013491","journal-title":"J Virol"},{"key":"566_CR221","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1128\/AAC.00146-11","volume":"55","author":"JA Lemm","year":"2011","unstructured":"Lemm JA, Leet JE, O\u2019Boyle DR, Romine JL, Huang XS, Schroeder DR, Alberts J, Cantone JL, Sun JH, Nower PT, Martin SW, Serrano-Wu MH, Meanwell NA, Snyder LB, Gao M (2011) Discovery of potent hepatitis C virus NS5A inhibitors with dimeric structures. Antimicrob Agents Chemother 55:3795\u20133802","journal-title":"Antimicrob Agents Chemother"},{"key":"566_CR222","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1128\/AAC.01186-12","volume":"56","author":"F McPhee","year":"2012","unstructured":"McPhee F, Sheaffer AK, Friborg J, Hernandez D, Falk P, Zhai G, Levine S, Chaniewski S, Yu F, Barry D, Chen C, Lee MS, Mosure K, Sun LQ, Sinz M, Meanwell NA, Colonno RJ, Knipe J, Scola P (2012) Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032). Antimicrob Agents Chemother 56:5387\u20135396","journal-title":"Antimicrob Agents Chemother"},{"key":"566_CR223","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep.26260","volume":"57","author":"K Esser-Nobis","year":"2013","unstructured":"Esser-Nobis K, Romero-Brey I, Ganten TM, Gouttenoire J, Harak C, Klein R, Schemmer P, Binder M, Schnitzler P, Moradpour D, Bartenschlager R, Polyak SJ, Stremmel W, Penin F, Eisenbach C, Lohmann V (2013) Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B. Hepatology 57:953\u2013963","journal-title":"Hepatology"},{"key":"566_CR224","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1053\/j.gastro.2014.07.019","volume":"147","author":"C Berger","year":"2014","unstructured":"Berger C, Romero-Brey I, Radujkovic D, Terreux R, Zayas M, Paul D, Harak C, Hoppe S, Gao M, Penin F, Lohmann V, Bartenschlager R (2014) Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Gastroenterology 147:1094\u20131105","journal-title":"Gastroenterology"},{"key":"566_CR225","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2014.04.021","volume":"147","author":"DR McGivern","year":"2014","unstructured":"McGivern DR, Masaki T, Williford S, Ingravallo P, Feng Z, Lahser F, Asante-Appiah E, Neddermann P, De Francesco R, Howe AY, Lemon SM (2014) Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors. Gastroenterology 147:453\u2013462","journal-title":"Gastroenterology"},{"key":"566_CR226","volume-title":"Global hepatitis report","author":"WHO","year":"2017","unstructured":"WHO (2017) Global hepatitis report. WHO, Geneva"},{"key":"566_CR227","first-page":"153","volume":"66","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver (2016) EASL recommendations on treatment of hepatitis C. J Hepatol 66:153\u2013194","journal-title":"J Hepatol"},{"key":"566_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.08.001","author":"M Guarino","year":"2018","unstructured":"Guarino M, Vigano L, Ponziani FR, Giannini EG, Lai Q, Morisco F (2018) Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: literature review and risk analysis. Dig Liver Dis. https:\/\/doi.org\/10.1016\/j.dld.2018.08.001","journal-title":"Dig Liver Dis"},{"key":"566_CR229","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virusres.2018.02.016","volume":"248","author":"R Bartenschlager","year":"2018","unstructured":"Bartenschlager R, Baumert TF, Bukh J, Houghton M, Lemon SM, Lindenbach BD, Lohmann V, Moradpour D, Pietschmann T, Rice CM, Thimme R, Wakita T (2018) Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. Virus Res 248:53\u201362","journal-title":"Virus Res"},{"key":"566_CR230","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2018.06.021","volume":"69","author":"AM Newsum","year":"2018","unstructured":"Newsum AM, Molenkamp R, van der Meer JT, Rebers SP, Prins M, van d V, Schinkel J (2018) Persistence of NS5B-S282T, a sofosbuvir resistance-associated substitution, in a HIV\/HCV-coinfected MSM with risk of onward transmission. J Hepatol 69:968\u2013970","journal-title":"J Hepatol"},{"key":"566_CR231","volume-title":"Combating hepatitis B and C to reach elimination by 2030","author":"WHO","year":"2016","unstructured":"WHO (2016) Combating hepatitis B and C to reach elimination by 2030. WHO, Geneva"},{"key":"566_CR232","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806\u2013811","journal-title":"Nature"},{"key":"566_CR233","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821","journal-title":"Science"},{"key":"566_CR234","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1128\/JVI.76.12.5974-5984.2002","volume":"76","author":"D Egger","year":"2002","unstructured":"Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K (2002) Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 76:5974\u20135984","journal-title":"J Virol"},{"key":"566_CR235","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1128\/JVI.77.9.5487-5492.2003","volume":"77","author":"R Gosert","year":"2003","unstructured":"Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, Bienz K, Moradpour D (2003) Identification of the hepatitis C virus RNA replication complex in huh-7 cells harboring subgenomic replicons. J Virol 77:5487\u20135492","journal-title":"J Virol"},{"key":"566_CR236","doi-asserted-by":"publisher","first-page":"e1003056","DOI":"10.1371\/journal.ppat.1003056","volume":"8","author":"I Romero-Brey","year":"2012","unstructured":"Romero-Brey I, Merz A, Chiramel A, Lee JY, Chlanda P, Haselman U, Santarella-Mellwig R, Habermann A, Hoppe S, Kallis S, Walther P, Antony C, Krijnse-Locker J, Bartenschlager R (2012) Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog 8:e1003056","journal-title":"PLoS Pathog"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-018-0566-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:57:00Z","timestamp":1744149420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-018-0566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":236,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2,4]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1007\/s00430-018-0566-x","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"10 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Volker Lohmann is co-owner of Reblikon GmbH, a company licensing the replicon system for commercial purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}